...
首页> 外文期刊>Cellular Physiology and Biochemistry >The Long Non-Coding RNA XIST Controls Non-Small Cell Lung Cancer Proliferation and Invasion by Modulating miR-186-5p
【24h】

The Long Non-Coding RNA XIST Controls Non-Small Cell Lung Cancer Proliferation and Invasion by Modulating miR-186-5p

机译:长的非编码RNA XIST通过调节miR-186-5p控制非小细胞肺癌的增殖和侵袭。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

>Background/Aims: Long non-coding RNAs (lncRNAs) are key players in the development and progression of human cancers. The lncRNA XIST (X-inactive specific transcript) has been shown to be upregulated in human non-small cell lung cancer (NSCLC); however, its role and molecular mechanisms in NSCLC cell progression remain unclear. Methods: qRT-PCR was conducted to assess the expression of XIST and miR-186. Cell proliferation was detected using MTT assay. Cell invasion and migration were evaluated using transwell assay. Cell cycle distribution and apoptosis rates were analyzed by flow cytometry. Luciferase reporter assay was used to identify the direct regulation of XIST and miR-186. A RNA immunoprecipitation was used to analyze whether XIST was associated with the RNA-induced silencing complex (RISC). Results: We confirmed that XIST was upregulated in NSCLC cell lines and tissues. Functionally, XIST knockdown inhibited cancer cell proliferation and invasion, and induced apoptosis in vitro, and suppressed subcutaneous tumor growth in vivo. Mechanistic investigations revealed a reciprocal repressive interaction between XIST and miR-186-5p. Furthermore, we showed that miR-186-5p has a binding site for XIST. Our data also indicated that XIST and miR-186-5p are likely in the same RNA induced silencing complex. Conclusion: Together, our data revealed that XIST knockdown confers suppressive function in NSCLC and XIST may be a novel therapeutic marker in this disease.
机译:> 背景/目标: 长的非编码RNA(lncRNA)是人类癌症发生和发展的关键因素。 lncRNA XIST(非X特异性转录物)在人非小细胞肺癌(NSCLC)中被上调;然而,其在NSCLC细胞进程中的作用和分子机制仍不清楚。 方法: 进行qRT-PCR评估XIST和miR-186的表达。使用MTT测定法检测细胞增殖。使用transwell测定法评估细胞的侵袭和迁移。流式细胞仪分析细胞周期分布和凋亡率。萤光素酶报告基因检测用于鉴定XIST和miR-186的直接调控。 RNA免疫沉淀用于分析XIST是否与RNA诱导的沉默复合物(RISC)相关。 结果: 我们证实XIST在NSCLC细胞系和组织中上调。在功能上,XIST抑制可抑制癌细胞的增殖和侵袭,并在体外诱导凋亡,并在体内抑制皮下肿瘤生长。机理研究表明,XIST和miR-186-5p之间存在相互抑制的相互作用。此外,我们表明miR-186-5p具有XIST的结合位点。我们的数据还表明,XIST和miR-186-5p可能在同一RNA诱导的沉默复合物中。 结论: 总之,我们的数据显示XIST敲除可赋予NSCLC抑制功能,XIST可能是该疾病的新型治疗标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号